Company intelligence / Profile preview

Cooperation

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Cooperation Pharmaceuticals is a clinical-stage biotechnology company based in Beijing, China, focused on the discovery and development of innovative small molecule and biologic therapies for oncology and inflammatory diseases. The company leverages its internal R&D capabilities to advance a pipeline of targeted therapies, including multi-kinase inhibitors and immune-oncology agents. Cooperation Pharmaceuticals aims to address unmet medical needs in the Chinese and global markets through strategic clinical development and partnerships. Their lead programs are currently undergoing evaluation in Phase 1 and Phase 2 clinical trials for various solid tumor indications.

Therapeutic areas: Oncology
Modalities: Small moleculeMonoclonal antibody
Industry: Biotech

Beyond the preview

Go deeper on Cooperation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cooperation.

Explore the full profile